Haoxi Health Technology Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Valuation Ratios
P/E Ratio0.95133.29
P/S Ratio0.113.55
P/B Ratio0.2115.27
Price/Tangible Book0.2415.27
Enterprise Value Ratios
EV/Revenue3.54
EV/EBITDA99.28
EV/EBIT99.90
Profitability & Returns
Return on Equity (ROE)0.27%0.20%19.24%
Return on Assets (ROA)-0.07%0.11%0.30%0.10%
Return on Invested Capital (ROIC)-0.23%0.36%
Return on Capital Employed (ROCE)-0.11%0.15%0.63%-0.18%-0.18%
Leverage & Solvency Ratios
Debt/Equity0.120.110.61-0.34-0.17
Debt/EBITDA0.700.681.380.85
Debt/FCF0.13
Liquidity Ratios
Current Ratio5.053.981.430.220.56
Quick Ratio2.401.840.490.210.18
Efficiency Ratios
Asset Turnover1.774.8611.289.63
Inventory Turnover5.8612.0821.4961.73
Yield & Distribution Ratios
Earnings Yield1.06%0.01%
FCF Yield-0.92%0.00%
Buyback Yield-0.96%-0.11%-0.10%